SCHEMBL7648802

SCHEMBL7648802

CC(C)CCC[C@@H](C)[C@H]1CC(O)[C@H]2[C@@H]3CC=C4C5(CC5)[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 4/20 0.55
▸ OSBP P22059 3/20 0.55
▸ LMNA P02545 3/20 0.55
▸ CYP46A1 Q9Y6A2 2/20 0.55
▸ RORC P51449 2/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ OSBP2 Q969R2 1/20 0.55
▸ SRD5A1 P18405 3/20 0.49
▸ NPC1L1 Q9UHC9 3/20 0.47
▸ POLA1 P09884 1/20 0.46
▸ NR1H3 Q13133 1/20 0.46
▸ GRIN1 Q05586 2/20 0.46
▸ GRIN2A Q12879 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ FNTA P49354 1/20 0.45
▸ FNTB P49356 1/20 0.45
▸ GRIN2B Q13224 1/20 0.44
▸ CDC25A P30304 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6389903 1.00 USP2 (0.55) USP2OSBPLMNACYP46A1RORC
SCHEMBL6387271 1.00 USP2 (0.55) USP2OSBPLMNACYP46A1RORC
SCHEMBL6389036 1.00 USP2 (0.55) USP2OSBPLMNACYP46A1RORC
SCHEMBL6387063 1.00 USP2 (0.55) USP2OSBPLMNACYP46A1RORC
SCHEMBL6392620 0.91 OSBP (0.53) USP2OSBPLMNACYP46A1RORC
SCHEMBL6388551 0.91 OSBP (0.53) USP2OSBPLMNACYP46A1RORC
SCHEMBL6391864 0.91 OSBP (0.53) USP2OSBPLMNACYP46A1RORC
SCHEMBL6388739 0.91 OSBP (0.53) USP2OSBPLMNACYP46A1RORC
SCHEMBL6388249 0.87 RORC (0.56) USP2OSBPLMNACYP46A1RORC
SCHEMBL6389183 0.87 RORC (0.56) USP2OSBPLMNACYP46A1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486145-B2 STEROL DERIVATIVE USEFUL IN TREATMENT OF FERTILITY NOVO NORDISK A/S (DK) 2002-11-26 — — US disclosed
US-20010005757-A1 Meiosis regulating compounds GRONDAHL CHRISTIAN (DK) 2001-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010005757-A1 Meiosis regulating compounds MNS1, NR5A1, NASP USP2 4505/4885OSBP 95/4885LMNA 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback